Release Date: 02/03/09 08:47 Summary: Half Yearly Report and Accounts Price Sensitive: Yes Download Document 297.94KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%